Bridging the Gaps: Treatment for Opioid Use Disorder
Bridging the Gaps: Treatment for Opioid Use Disorder
This course examines treatment for opioid use disorder (OUD) from a clinical and research perspective. It will review approved medications and their pharmacology, efficacy and safety. Panelists will discuss these lifesaving medications (currently underutilized), describe characteristics of Medicare beneficiaries with OUD and highlight disparities and gaps in access to medications for treating OUD among underserved Medicare populations. The course will close with a discussion of successful models for implementation of primary care-based treatment of OUD.
Click here to access the Quality Innovation Series registration page to register or review the full course content.
- Summarize core principles and evidence supporting use of medications to treat OUD.
- Describe characteristics of Medicare beneficiaries with OUD.
- Identify disparities and gaps in access to medications for treating OUD among underserved Medicare populations, based on sociodemographic and health condition characteristics.
- Describe the components of successful primary care-based models of treating OUD.
Daniel P. Alford, MD, MPH
Daniel P. Alford, MD, MPH, is Professor of Medicine and Associate Dean of Continuing Medical Education at Boston University School of Medicine (BUSM). He is on staff in the Section of General Internal Medicine and is Director of the Clinical Addiction Research and Education (CARE) Unit at Boston Medical Center. He is also Director of the BUSM Safer/Competent Opioid Prescribing Education (SCOPE of Pain) program, which has trained over 250,000 health care providers nationally. He is past-president of the Association for Multidisciplinary Education and Research in Substance use and Addiction (AMERSA). He has been recognized as a Champion of Change by the White House and has received the American Medical Association’s Award for Health Education, the American Society of Addiction Medicine Educator of the Year Award, the American College of Physicians Award for Distinguished Contributions to Behavioral Medicine and the AMERSA McGovern Award for Excellence in Medical Education. His clinical, educational and research interests focus on managing opioid use disorders and safer and more competent opioid prescribing for managing pain.
Judy Ng, PhD, MPH
Judy Ng, PhD, MPH, is a Research Scientist at NCQA. Dr. Ng’s research and professional work has focused on the impact of opioid prescribing practices and inequities in access to medication treatment for opioid use disorder, health care quality, and the effect of Medicare and Medicaid policies on underserved populations. She has published on health care access and quality gaps that affect underserved populations; racial, ethnic and gender inequities in care among older adults; and the conceptual underpinnings of health inequities. Dr. Ng has developed performance measures assessing quality of care across diverse settings, from immunizations and preventive care to the management of chronic conditions. Recently, her work on opioid use disorder treatment supported federal policy changes that will reduce inequities in pain management for people with sickle cell disease, many of whom are racial and ethnic minorities, and improve their health outcomes. Dr. Ng has served on technical expert panels for the National Institutes of Health, the American College of Surgeons, and the National Quality Forum. She has a PhD in public health from Johns Hopkins University and an MPH from Columbia University.
In support of improving patient care, the National Committee for Quality Assurance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), the American Academy of Physician Assistants (AAPA), the American Psychological Association (APA), and the Association of Social Work Boards (ASWB) to provide Interprofessional Continuing Education for the healthcare team.
This educational activity is approved for a maximum of 1.0 AMA PRA Category 1 Credit™.
This educational activity is approved for 1.0 nursing contact hours.*
This live course grants 1.0 Continuing Education Unit (CEU) points for PCMH Certified Content Experts.
* Please note – You must attend the entire program to be eligible for total number of contact hours.
Disclosure of Relevant Financial Relationships
The National Committee for Quality Assurance (NCQA) endorses the Standards of the Accreditation Council for Continuing Medical Education which specify that sponsors of continuing medical education activities and presenters at and planners for these activities disclose any relevant financial relationships either party might have with commercial companies whose products or services are discussed in educational presentations.
For sponsors, relevant financial relationships include large research grants, institutional agreements for joint initiatives, substantial gifts, or other relationships that benefit the institution. For presenters or planning committee members, relevant financial relationships include the receipt of research grants from a commercial company, consultancies, honoraria, travel, or other benefits, or having a self-managed equity interest in a company; or having an immediate family member or partner with such a relationship.
Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Relevant financial relationships exist with the following companies/organizations:
Judy Ng: None
Dan Alford: None
Additional Planning Committee Members:
Crissy Crittenden: None
This program was developed in part by NCQA staff.
This program received no commercial support.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
- 1.00 PCMH CCE